Track Aeva Technologies Inc (AEVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell ...Track Cassava Sciences Inc (SAVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Arm Holdings Plc. (ARM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack CytoDyn Inc (CYDY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--May 31, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.Verastem's stockholders approved an amendment to Verastem's Restated Certificate of Incorporation (as amended, the ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Latest VERASTEM (VSTM) stock news, Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developin... Close. Discover the power of a Real-Time Financial News Database! ... Import your watchlist from Stocktwits and get a realtime overview of all news articles published regarding your favorite symbols ...Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Verastem Inc (VSTM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Insiders have sold a total of 16,432 Verastem shares in the last 24 months for a total of $168,350.95 sold. This page (NASDAQ:VSTM) was last updated on 5/25/2024 by MarketBeat.com Staff.Verastem Stock Up 9.5 %. NASDAQ VSTM opened at $13.16 on Monday. Verastem has a 52 week low of $4.68 and a 52 week high of $15.18. The company has a quick ratio of 4.40, a current ratio of 4.40 ...By: Brian Stuglik, CEO, Verastem Oncology. Over the past year, those of us working in pharmaceutical oncology R&D have watched with awe as industry colleagues worked together to speed vaccinations for COVID-19 from the lab to patients’ arms in record time. Breakthroughs in cancer research, typically don’t happen that quickly.Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients ...Verastem gets $3.8M award for VS-6766/defactinib combo trial to treat pancreatic cancer SA News Wed, May 18, 2022. Verastem Non-GAAP EPS of -$0.08 beats by $0.01, revenue of $2.6M beats by $1.1MAt Verastem Oncology, we're on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It's through these collaborations that we'll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.Summary. Verastem's stock plummeted after updates showed reduced efficacy in cancer treatment trials, causing a reassessment of strategy. Updated clinical …Verastem Oncology (Verastem Inc) is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts , the firm is a member of NASDAQ Biotechnology Index .Track Vermilion Energy Inc (VET) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Verastem Inc (VSTM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the …Verastem Oncology, Inc. (NASDAQ: VSTM), is a biopharmaceutical company headquartered in Needham, MA. The focus of our research is developing a portfolio of novel small molecule drugs that inhibit critical RAS signaling pathways that promote cancer cell survival and tumor growth. To learn more about our research …[email protected]. Argot Partners Nate LiaBraaten +1 212-600-1902 [email protected]. Media: Lisa Buffington Corporate Communications +1 781-292-4205 [email protected]. Source: Verastem Oncology6 equities research analysts have issued 1 year price objectives for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they expect the company's share price to reach $28.79 in the next year. This suggests a possible upside of 598.7% from the stock's current price.Serena Williams was fined a total of $17,000 for three code violations under Carlos Ramos in her loss to Naomi Osaka in the U.S. Open final. By clicking "TRY IT", I agree to receiv...Joined 1/2015. 10 Following 54.4k Followers. Posts. The latest messages and market ideas from Jared Wesley (@ScalpMaster) on Stocktwits. 18 year professional trader enjoying the perks and lifestyle this business affords. [email protected] News. 1 day ago - Verastem opened 70% down on Friday: what happened? - Invezz ; 1 day ago - Harvest ETFs announces May 2024 Distributions - Business Wire 1 day ago - Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade ...We would like to show you a description here but the site won’t allow us.Stocktwits is the leading social platform for investors and traders to share ideas, insights and opinions about the stock, crypto and international markets. Join the Stocktwits community, follow your favorite symbols, get real-time quotes, news, earnings and fundamentals, and buy US stocks with ease.Seanergy Maritime Holdings Corp. analysts consensus, targets, ratings and recommendations | Nasdaq: SHIP | NasdaqBOSTON--(BUSINESS WIRE)--Jun. 15, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and pre-funded warrants in an underwritten public offering.In connection with the proposed offering, Verastem Oncology intends to grant the underwriters ...At Verastem Oncology, we’re committed to ensuring options exist. For more information about the work we’re doing at Verastem Oncology, please access our Resources section or contact Julissa Viana via email at [email protected] the latest Abeona Therapeutics Inc. (ABEO) stock quote, history, news and other vital information to help you with your stock trading and investing.Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019-)Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack REMSleep Holdings, Inc (RMSL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019–)Track Actinium Pharmaceuticals Inc (ATNM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack MicroCloud Hologram Inc (HOLO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors5 days ago · www.verastem.com. Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma RAF/MEK, ERK mitogen activated pathway kinase ...Novel therapies and combinations are urgently needed to deliver on the promise of better outcomes for patients. Find out more about our clinical trials. At Verastem Oncology, we recognize and prioritize the importance of partnership with the research and patient advocacy communities to create and support approaches to better care.Track Vivos Therapeutics Inc (VVOS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack American Virtual Cloud Technologies Inc (AVCTQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 22,500 shares of its common stock and the grant of 15,000 restricted stock units to one new employee. The stock options have an exercise price equal to $0.87 per share, the closing ...Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 cohort of its early to mid-stage study evaluating avutometinib and …Watertown, Mass. (February 7, 2024) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced that management will participate in several upcoming investor conferences: Oppenheimer 34th Annual …BOSTON, May 31, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 ...Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--May 31, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.Verastem’s stockholders approved an …0.0563. -13.38%. ADVMAdverum Biotechnologies, Inc. 7.90. +0.51%. Find the latest Pieris Pharmaceuticals, Inc. (PIRS) stock quote, history, news and other vital information to help you with your ...Track CytoDyn Inc (CYDY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStocktwits is the leading social platform for investors and traders to share ideas, insights and opinions about the stock, crypto and international markets. Join the Stocktwits community, follow your favorite symbols, get real-time quotes, news, earnings and fundamentals, and buy US stocks with ease.Verastem Oncology aims to change that by relentlessly pursuing RAS-targeted treatment combinations with avutometinib. We’re driven to develop treatments that give patients more choices and the possibility of better outcomes. Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients ...STOCKTWITS; INSIDER TRADING; SENTIMENT ANALYSIS; MANAGER PORTFOLIOS; LATE CORPORATE NEWS . Verastem, Inc. (VSTM) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023. Home. SEC Filings. ... Inside Verastem, Inc.'s 10-K Annual Report: Other - Other Highlight.Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients.Insiders have sold a total of 16,432 Verastem shares in the last 24 months for a total of $168,350.95 sold. This page (NASDAQ:VSTM) was last updated on 5/25/2024 by MarketBeat.com Staff.Comprehensive suite of tools for trading and investing in biotech stocks. FDA Calendar, PDUFA Date Calendar, Biotech Company Screener and Database and much moreBOSTON, May 23, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine and Nab .... Latest VPER News. No VPER news at the moment. Track Viper NVerastem, Inc., operating as Verastem Oncology, BOSTON--(BUSINESS WIRE)--Jun. 16, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in …May 25, 2023 · Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ... BOSTON, May 23, 2024--Verastem Oncology (Nasdaq: VST Our ambition is prevention and cure. Our universal technology can be used in prophylaxis or therapy. It is based on a patent-protected family of engineered viruses, which naturally elicit neutralizing antibodies and extremely potent T cell responses. The efficacy of our TheraT® and Vaxwave® platforms are being tested all across our pipeline. Verastem Oncology, a biopharmaceutical company committed to advancing...
Continue Reading